FY2025 EPS Estimates for Revvity Reduced by Leerink Partnrs

Key Points

• Leerink Partners has revised its FY2025 earnings per share estimate for Revvity Inc. down from $4.94 to $4.88.
• Several analysts have issued changes to Revvity's target prices, with JPMorgan lowering it from $120.00 to $100.00 and Raymond James adjusting theirs from $120.00 to $115.00.
• Revvity has announced a quarterly dividend of $0.07 per share, with the ex-dividend date set for October 17th.

Revvity Inc. (NYSE:RVTY - Free Report) - Leerink Partnrs reduced their FY2025 earnings per share estimates for Revvity in a research note issued on Monday, July 28th. Leerink Partnrs analyst P. Souda now expects that the company will post earnings per share of $4.88 for the year, down from their prior forecast of $4.94. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Leerink Partnrs also issued estimates for Revvity's Q1 2026 earnings at $1.15 EPS and Q3 2026 earnings at $1.40 EPS.

A number of other research analysts have also recently issued reports on RVTY. Bank of America lowered their price target on shares of Revvity from $116.00 to $110.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. Stifel Nicolaus decreased their target price on shares of Revvity from $120.00 to $110.00 and set a "hold" rating for the company in a research note on Tuesday. Wall Street Zen raised shares of Revvity from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. The Goldman Sachs Group decreased their target price on shares of Revvity from $140.00 to $125.00 and set a "buy" rating for the company in a research note on Tuesday, April 29th. Finally, Evercore ISI decreased their target price on shares of Revvity from $116.00 to $115.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $120.07.

Revvity Stock Up 0.3%

Revvity stock traded up $0.30 on Thursday, hitting $88.20. 1,601,103 shares of the stock traded hands, compared to its average volume of 1,476,599. Revvity has a 1 year low of $85.80 and a 1 year high of $129.50. The firm has a market cap of $10.40 billion, a P/E ratio of 37.37, a price-to-earnings-growth ratio of 2.36 and a beta of 0.98. The company has a current ratio of 3.33, a quick ratio of 2.99 and a debt-to-equity ratio of 0.43. The business's fifty day simple moving average is $95.51 and its 200 day simple moving average is $102.52.

Revvity (NYSE:RVTY - Get Free Report) last announced its earnings results on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.14 by $0.04. Revvity had a return on equity of 7.66% and a net margin of 10.19%. The firm had revenue of $720.28 million during the quarter, compared to analyst estimates of $711.26 million. During the same quarter in the prior year, the company earned $1.22 EPS. The business's revenue was up 4.1% compared to the same quarter last year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Friday, October 17th. Revvity's dividend payout ratio is 11.86%.

Hedge Funds Weigh In On Revvity

Institutional investors and hedge funds have recently made changes to their positions in the business. Optiver Holding B.V. bought a new position in shares of Revvity in the fourth quarter worth about $33,000. Quarry LP raised its stake in shares of Revvity by 45.7% in the fourth quarter. Quarry LP now owns 303 shares of the company's stock worth $34,000 after buying an additional 95 shares during the period. UMB Bank n.a. raised its stake in shares of Revvity by 138.8% in the second quarter. UMB Bank n.a. now owns 406 shares of the company's stock worth $39,000 after buying an additional 236 shares during the period. CVA Family Office LLC raised its stake in shares of Revvity by 79.0% in the second quarter. CVA Family Office LLC now owns 410 shares of the company's stock worth $40,000 after buying an additional 181 shares during the period. Finally, Vermillion Wealth Management Inc. bought a new position in shares of Revvity in the fourth quarter worth about $41,000. Hedge funds and other institutional investors own 86.65% of the company's stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.